NYSE

abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)

♥ 540 Thanks from members

Live price chart, market sentiment, and community perspectives for abrdn Life Sciences Investors Shares of Beneficial Interest (NYSE: HQL).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: Closed-End Healthcare FundsFounder: abrdn Investment ManagementLeadership: Alastair Irvine (Portfolio Manager)Leadership: Erin Barker (Portfolio Manager)Holder: abrdn Inc.Holder: Institutional InvestorsLife Sciences Common SharesClosed-End Biotech Portfolio#HQL#abrdn Life Sciences Investors#Healthcare CEF#NYSE HQL#Biotech Fund